A personal account of the small worries and the shifting relationship with food that he says come with these drugs, written for people who have never taken them.
Recap by typeshit. Post by @gerardsglp1journey on Instagram.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
The TRANSCEND-T2D-1 results in The Lancet covered 537 adults over 40 weeks, with HbA1c falling as much as 1.94 points at the top 12 mg dose versus placebo.
The GLP-1/GIP drug hit up to 19% mean weight loss over 48 weeks in a Chinese phase 3, with fewer GI side effects, Regeneron says. US trials are still ahead.
Loading…